Terms: = Head and neck cancer AND CDH1, uvomorulin, 999, P12830, ENSG00000039068, CDHE, Arc-1, UVO, LCAM, CD324, ECAD AND Clinical Outcome
11 results:
1. Mutation allele frequency threshold does not affect prognostic analysis using next-generation sequencing in oral squamous cell carcinoma.
Ma J; Fu Y; Tu YY; Liu Y; Tan YR; Ju WT; Pickering CR; Myers JN; Zhang ZY; Zhong LP
BMC Cancer; 2018 Jul; 18(1):758. PubMed ID: 30041611
[TBL] [Abstract] [Full Text] [Related]
2. Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma.
Salem ME; Puccini A; Xiu J; Raghavan D; Lenz HJ; Korn WM; Shields AF; Philip PA; Marshall JL; Goldberg RM
Oncologist; 2018 Nov; 23(11):1319-1327. PubMed ID: 29866946
[TBL] [Abstract] [Full Text] [Related]
3. Time to diagnosis in esophageal cancer: a cohort study.
Cavallin F; Scarpa M; Cagol M; Alfieri R; Ruol A; Chiarion Sileni V; Rugge M; Ancona E; Castoro C
Acta Oncol; 2018 Sep; 57(9):1179-1184. PubMed ID: 29600882
[TBL] [Abstract] [Full Text] [Related]
4. A three-gene signature from protein-protein interaction network of LOXL2- and actin-related proteins for esophageal squamous cell carcinoma prognosis.
Zhan XH; Jiao JW; Zhang HF; Li CQ; Zhao JM; Liao LD; Wu JY; Wu BL; Wu ZY; Wang SH; Du ZP; Shen JH; Zou HY; Neufeld G; Xu LY; Li EM
Cancer Med; 2017 Jul; 6(7):1707-1719. PubMed ID: 28556501
[TBL] [Abstract] [Full Text] [Related]
5. Discovery of a Good Responder Subtype of Esophageal Squamous Cell Carcinoma with Cytotoxic T-Lymphocyte Signatures Activated by Chemoradiotherapy.
Tanaka Y; Aoyagi K; Minashi K; Komatsuzaki R; Komatsu M; Chiwaki F; Tamaoki M; Nishimura T; Takahashi N; Oda I; Tachimori Y; Arao T; Nishio K; Kitano S; Narumi K; Aoki K; Fujii S; Ochiai A; Yoshida T; Muto M; Yamada Y; Sasaki H
PLoS One; 2015; 10(12):e0143804. PubMed ID: 26625258
[TBL] [Abstract] [Full Text] [Related]
6. Co-Expression of TWIST1 and ZEB2 in Oral Squamous Cell Carcinoma Is Associated with Poor Survival.
Kong YH; Syed Zanaruddin SN; Lau SH; Ramanathan A; Kallarakkal TG; Vincent-Chong VK; Wan Mustafa WM; Abraham MT; Abdul Rahman ZA; Zain RB; Cheong SC
PLoS One; 2015; 10(7):e0134045. PubMed ID: 26214683
[TBL] [Abstract] [Full Text] [Related]
7. Epigenetic inactivation of the E-cadherin gene in eyelid sebaceous gland carcinoma.
Jayaraj P; Sen S; Sharma A; Chosdol K; Kashyap S; Rai A; Pushker N; Bajaj MS; Ghose S
Br J Dermatol; 2012 Sep; 167(3):583-90. PubMed ID: 22458737
[TBL] [Abstract] [Full Text] [Related]
8. Biomarker analysis of cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric and oesophago-gastric junction cancer: results from a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO).
Luber B; Deplazes J; Keller G; Walch A; Rauser S; Eichmann M; Langer R; Höfler H; Hegewisch-Becker S; Folprecht G; Wöll E; Decker T; Endlicher E; Lorenzen S; Fend F; Peschel C; Lordick F
BMC Cancer; 2011 Dec; 11():509. PubMed ID: 22152101
[TBL] [Abstract] [Full Text] [Related]
9. Functional polymorphisms associated with disease-free survival in resected carcinoma of the esophagus.
Boonstra JJ; van Marion R; Tilanus HW; Dinjens WN
J Gastrointest Surg; 2011 Jan; 15(1):48-56. PubMed ID: 20922573
[TBL] [Abstract] [Full Text] [Related]
10. [Nasosinusal adenocarcinoma: molecular and genetic analysis by MLPA].
Llorente JL; Aldama P; Alvarez-Marcos C; Escudero J; Alonso-Guervós M; Fresno F; Suárez C; Hermsen M
Acta Otorrinolaringol Esp; 2008 Apr; 59(4):151-8. PubMed ID: 18447972
[TBL] [Abstract] [Full Text] [Related]
11. Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome.
Pyo SW; Hashimoto M; Kim YS; Kim CH; Lee SH; Johnson KR; Wheelock MJ; Park JU
J Craniomaxillofac Surg; 2007 Jan; 35(1):1-9. PubMed ID: 17296306
[TBL] [Abstract] [Full Text] [Related]
